Dentist

Q&M Dental Group recorded growth in both Revenue and Net Profit after tax attributable to parent of S$182.7 million and S$11.5 million respectively for FY2023

Retrieved on: 
Friday, March 1, 2024
Philosophy, COVID-19, Morale, SARS-CoV-2, Dentist, Culture, Into, Growth, Dentistry, Nursing, COVID-19 testing, Patient, Tax, Knowledge, Artificial intelligence, Research, Depreciation

Comparing FY2023 with FY2022, share of loss in Aoxin Q & M, decreased by S$0.5 million for the same reason give above.

Key Points: 
  • Comparing FY2023 with FY2022, share of loss in Aoxin Q & M, decreased by S$0.5 million for the same reason give above.
  • This is mainly attributable to operating cash flow before changes in working capital offset by increase on working capital.
  • As at 31 December 2023, Q & M has cash and cash equivalents of S$34.0 million and bank borrowings plus finance leases amounting to S$80.3 million.
  • Net Aset Value attributable to owners of parent is S$99.1 million as at 31 December 2023 compared to S$96.5 million a year ago, an increase of 3%.

INMODE LTD. (NASDAQ: INMD) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against InMode Ltd.

Retrieved on: 
Monday, March 11, 2024
Court, Action Replay, Dentist, News, Advertising, Complaint, District court, Food and Drug Administration, Dermatology

If you purchased or acquired InMode common stock, and/or would like to discuss your legal rights and options please visit InMode Ltd.

Key Points: 
  • If you purchased or acquired InMode common stock, and/or would like to discuss your legal rights and options please visit InMode Ltd.
  • If you wish to serve as lead plaintiff, you must move the Court no later than April 15, 2024.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NYCB, LuxUrban, InMode, and Lantronix and Encourages Investors to Contact the Firm

Retrieved on: 
Sunday, March 10, 2024
Complaint, Analysis, Letter, Internet, New York Community Bank, Intelligence, Assumption, FDA, News, Internet of things, Dentist, Confidentiality, Injury, Transport, NYCB, ACL, City, Royalton Hotel, Food and Drug Administration, Signature, Result, EPS, Defendant, IOT, Dermatology, Category, P.C

NYCB is a large commercial-real estate lender in the New York City market area, where it specializes in rent-regulated, non-luxury apartment buildings.

Key Points: 
  • NYCB is a large commercial-real estate lender in the New York City market area, where it specializes in rent-regulated, non-luxury apartment buildings.
  • NYCB is engaged in several national businesses, including multi-family lending, mortgage originations and servicing, and warehouse lending.
  • On January 31, 2024, before the market opened, NYCB announced its fiscal fourth quarter 2023 financial results.
  • Following these disclosures, Lantronix's stock price fell $1.89 per share, or 32.53%, to close at $3.92 per share on February 9, 2024.

Benevis Celebrates Dental Assistants Recognition Week

Retrieved on: 
Friday, March 8, 2024
DA, Education, Dental, Dental care, Dentist, Dentistry, Patient, Hygiene

Atlanta, GA, March 08, 2024 (GLOBE NEWSWIRE) -- Benevis , a leading dental healthcare and orthodontics delivery organization committed to providing quality care to underserved communities, celebrates Dental Assistants Recognition Week, March 3 through March 9, 2024.

Key Points: 
  • Atlanta, GA, March 08, 2024 (GLOBE NEWSWIRE) -- Benevis , a leading dental healthcare and orthodontics delivery organization committed to providing quality care to underserved communities, celebrates Dental Assistants Recognition Week, March 3 through March 9, 2024.
  • "We are honored to recognize the many wonderful contributions of our 750 Dental Assistants during this special celebratory week.
  • To honor Dental Assistants Recognition Week, Benevis has provided each office with a stipend to organize a personalized celebration for the Dental Assistants.
  • For Dental Assistants and dental professionals interested in joining Benevis, visit https://careers.benevis.com/careers for more information.

INMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that InMode Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Wednesday, March 6, 2024
Court, Person, Dentist, FDA, Confidentiality, Injury, Complaint, Food and Drug Administration, Dermatology

InMode is a global provider of aesthetic medical devices and technology including devices purporting to offer body sculpting and other rejuvenation technologies.

Key Points: 
  • InMode is a global provider of aesthetic medical devices and technology including devices purporting to offer body sculpting and other rejuvenation technologies.
  • Specifically, Defendants repeatedly touted the demand for InMode’s devices and told investors that those devices were never sold at a discount.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against InMode, Lantronix, Palo Alto Networks, and Snowflake and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, March 5, 2024
Complaint, Palo Alto Networks, Internet, Intelligence, Dentist, PANW, FDA, Transport, Internet of things, Snowflake Inc., Injury, Confidentiality, Growth, Federation, IPO, City, Food and Drug Administration, News, SNOW, EPS, IOT, Defendant, Dermatology, P.C, Audit

InMode is a global provider of aesthetic medical devices and technology, including devices purporting to offer body sculpting and other rejuvenation technologies.

Key Points: 
  • InMode is a global provider of aesthetic medical devices and technology, including devices purporting to offer body sculpting and other rejuvenation technologies.
  • Specifically, Defendants repeatedly touted the demand for InMode’s devices and told investors that those devices were never sold at a discount.
  • The customers also stated that InMode offered to replace defective products on the condition of signing confidentiality agreements with non-disparagement clauses.
  • which lowered credit consumption.”  On this news, the price of Snowflake Class A common stock fell nearly 28% over several trading sessions, damaging investors.

INMODE LTD. (NASDAQ: INMD) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against InMode Ltd.

Retrieved on: 
Monday, March 4, 2024
Court, Action Replay, Dentist, News, Advertising, Complaint, District court, Food and Drug Administration, Dermatology

If you purchased or acquired InMode common stock, and/or would like to discuss your legal rights and options please visit InMode Ltd.

Key Points: 
  • If you purchased or acquired InMode common stock, and/or would like to discuss your legal rights and options please visit InMode Ltd.
  • If you wish to serve as lead plaintiff, you must move the Court no later than April 15, 2024.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against InMode, Lantronix, and Palo Alto Networks and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, March 2, 2024
Complaint, Palo Alto Networks, Internet, Intelligence, Dentist, PANW, FDA, Transport, Internet of things, Confidentiality, Injury, News, Growth, Federation, City, Food and Drug Administration, EPS, IOT, Defendant, Dermatology, P.C

InMode is a global provider of aesthetic medical devices and technology, including devices purporting to offer body sculpting and other rejuvenation technologies.

Key Points: 
  • InMode is a global provider of aesthetic medical devices and technology, including devices purporting to offer body sculpting and other rejuvenation technologies.
  • Specifically, Defendants repeatedly touted the demand for InMode’s devices and told investors that those devices were never sold at a discount.
  • On this news, the price of Palo Alto Networks, Inc. common stock declined by $104.12 per share, or approximately 28%, on February 21, 2024.
  • For more information on the Palo Alto Networks class action go to: https://bespc.com/cases/PANW

FSIS Commends Appointment of Dr. Kis Robertson Hale as Chief Veterinarian Officer of USPHS

Retrieved on: 
Friday, March 1, 2024
Human services, USPHS, Poultry, Physician, Dentist, Surgeon, Food, Farmer, Commission, Veterinarian, Meat, Public health, Health, COVID-19, Nursing, FSIS, USDA, Public, Livestock

WASHINGTON, March 01, 2024 (GLOBE NEWSWIRE) -- The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) commends the appointment by the U.S. Public Health Service (USPHS) of Dr. Kis Robertson Hale as Chief Veterinarian Officer.

Key Points: 
  • WASHINGTON, March 01, 2024 (GLOBE NEWSWIRE) -- The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) commends the appointment by the U.S. Public Health Service (USPHS) of Dr. Kis Robertson Hale as Chief Veterinarian Officer.
  • Dr. Robertson Hale is a Rear Admiral in the USPHS Commissioned Corps and serves as FSIS’ Chief Public Health Veterinarian and Deputy Assistant Administrator of the Office of Public Health Science, positions that she will continue to hold.
  • In her new appointment as Chief Veterinarian Officer of the USPHS, Dr. Robertson Hale will provide expert guidance to the Office of the Surgeon General and the U.S. Department of Health and Human Services on matters related to veterinary recruitment, assignment, deployment, retention and career development.
  • Robertson Hale’s appointment as Chief Veterinarian Officer by the U.S.

INMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that InMode Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Wednesday, February 28, 2024
Court, Person, Dentist, FDA, Confidentiality, Injury, Complaint, Food and Drug Administration, Dermatology

InMode is a global provider of aesthetic medical devices and technology including devices purporting to offer body sculpting and other rejuvenation technologies.

Key Points: 
  • InMode is a global provider of aesthetic medical devices and technology including devices purporting to offer body sculpting and other rejuvenation technologies.
  • Specifically, Defendants repeatedly touted the demand for InMode’s devices and told investors that those devices were never sold at a discount.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.